Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• GSI Technology, Inc. GSIT shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16, 2023.
• ARS Pharmaceuticals, Inc. SPRY shares jumped 82.8% to $8.27 after the company reported the FDA's Advisory Committee voted in support of favorable benefit-risk assessment for neffy in the treatment of severe allergic reactions (Type 1), including anaphylaxis.
• Getaround, Inc. GETR shares climbed 73.6% to $0.5749 after the company announced it is acquiring substantially all of the assets of HyreCar for an aggregate purchase price of $9.45 million.
• Dermata Therapeutics, Inc. DRMA shares climbed 45.1% to $2.80 after the company highlighted recent corporate progress, and reported financial results for the first quarter.
• Jupiter Wellness Acquisition Corp. JWAC surged 40% to $7.10.
• Blue Bird Corporation BLBD gained 38.7% to $26.80 after the company reported better-than-expected Q2 results.
• AirSculpt Technologies, Inc. AIRS shares climbed 32.8% to $6.50 after the company reported better-than-expected Q1 financial results.
• Arlo Technologies, Inc. ARLO gained 24.3% to $8.76 following strong quarterly results.
• Greenbrook TMS Inc. GBNH rose 23.2% to $0.77.
• First Solar, Inc. FSLR surged 21.9% to $223.36 after the company announced the acquisition of Evolar.
• Ouster, Inc. OUST gained 19.3% to $4.58 following strong Q1 sales results.
• VYNE Therapeutics Inc. VYNE gained 19.3% to $7.28 after the company reported Q1 financial results.
• Array Technologies, Inc. ARRY jumped 18.6% to $22.47 following strong quarterly results.
• SurgePays, Inc. SURG gained 14.7% to $5.06 after the company reported Q1 financial results.
• Pharming Group N.V. PHAR rose 14.5% to $11.69. Pharming recently posted a Q1 loss of $0.02 per share.
• P3 Health Partners Inc. PIII jumped 14.3% to $2.64. P3 Health Partners recently posted upbeat quarterly results.
• Holley Inc. HLLY gained 12.8% to $3.07. Telsey Advisory Group and Raymond James raised their price targets on the stock.
• Cidara Therapeutics, Inc. CDTX rose 9.3% to $1.29 following better-than-expected quarterly sales.
• Hallmark Financial Services, Inc. HALL gained 9.1% to $4.31.
• News Corporation NWS surged 6.7% to $17.97 following Q3 results.

Losers

• Assure Holdings Corp. IONM fell 37.8% to $1.20 after the company announced pricing of a $6 million underwritten public offering.
• Heron Therapeutics, Inc. HRTX dropped 33.9% to $1.4750 after the company reported mixed Q1 financial results.
• TOP Financial Group Limited TOP shares fell 29.7% to $6.42 after the SEC said it is temporarily suspending trading in the securities of the company because of "recent, unusual, and unexplained market activity" raising concerns regarding the adequacy and accuracy of publicly-available information.
• AVITA Medical, Inc. RCEL dropped 24.3% to $11.89 after the company reported mixed Q1 financial results.
• Freight Technologies, Inc. FRGT declined 23% to $1.54 after the company reported preliminary Q1 2023 revenue of $3.3 million, down from $5.3 million for Q1 prior year 2022.
• Intrusion Inc. INTZ dropped 22.9% to $1.31 following weak quarterly results.
• BitNile Metaverse, Inc. BNMV fell 22.3% to $0.0449 after the company announced a 1-for-30 reverse stock split.
• Audacy, Inc. AUD dropped 20.6% to $0.1086. Audacy recently reported mixed Q1 financial results.
• Impel Pharmaceuticals Inc. IMPL fell 19.7% to $1.83 after the company reported a decrease in year-over-year Q1 EPS results and worse-than-expected Q1 sales results.
• Check-Cap Ltd. CHEK dropped 19% to $1.49 following a wider-than-expected quarterly loss.
• Dingdong (Cayman) Limited DDL fell 18.7% to $3.2820 after the company reported worse-than-expected Q1 sales results.
• Hepion Pharmaceuticals, Inc. HEPA fell 18.5% to $6.74.
• Akumin Inc. AKU dipped 18.4% to $0.4260. Akumin recently posted a wider quarterly loss.
• ImmunityBio, Inc. IBRX dropped 18% to $2.2850 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $10 to $4.
• Hepion Pharmaceuticals, Inc. HEPA dipped 17% to $6.86.
• Cemtrex, Inc. CETX fell 16.5% to $9.10 after the company reported Q2 results.
• Harrow Health, Inc. HROW dropped 16.3% to $22.66 after the company reported Q1 financial results.
• VCI Global Limited VCIG fell 14.8% to $3.00 after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.
• Youdao, Inc. DAO dropped 14.4% to $5.42.
• OraSure Technologies, Inc. OSUR fell 13.8% to $6.37. OraSure Technologies recently posted upbeat quarterly results.
• Emergent BioSolutions Inc. EBS dropped 12.5% to $9.19. Emergent BioSolutions recently reported better-than-expected Q1 sales results.
• Marinus Pharmaceuticals, Inc. MRNS declined 10.6% to $8.27. Marinus Pharmaceuticals reported Q1 financial results.
• IonQ, Inc. IONQ shares fell 9.8% to $6.32 after the quantum computing company reported first-quarter financial results.
• Bellicum Pharmaceuticals, Inc. BLCM shares dropped 9.7% to $0.7210. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.
• Definitive Healthcare Corp. DH dropped 9% to $8.89.
• MMTec, Inc. MTC fell 8.2% to $1.01 after gaining more than 5% on Thursday.
• Unique Fabricating, Inc. UFAB fell 7.4% to $0.2453 after dropping 16% on Thursday.
• IHS Holding Limited IHS dropped 7.3% to $8.40.
• BIOLASE, Inc. BIOL shares dropped 6.8% to $0.2236 after the company posted Q1 results.

Now Read This: Bitcoin Tumbles Below This Key Level Following Economic Data; Pepe, Huobi Token Among Top Losers